• About
  • Research
  • Publications
  • Conference
  • Training
  • Teaching
  • Skills
  • CV

Prevalence of hyperlipidemia in controlled and uncontrolled type‑2 diabetic patients

Research
Endocrinology
Public Health
Author

Mohammad Abul Hasnat, Farhan Rahman Niloy, Arafat Islam Ashik, Mahedi Hasan, Preonath Chondrow Dev, Sharmin Sultana Panna, Md. Waseque Mia, Zafrul Hasan

Doi

10.5455/jabet.2022.d112

Abstract

Patients with type-2 diabetes mellitus (T2DM) are known to suffer from hyperlipidemia. How hyperlipidemia is associated with controlled and uncontrolled T2DM patients in Bangladesh remained to be addressed. In this cross-sectional study, 211 participants were enrolled who have been suffering from T2DM for more than 4 years from the northeastern part of Bangladesh. Controlled and uncontrolled patients were defined with their plasma glycated hemoglobin (HbA1c) levels. Among them, 39% and 61% were in the diabetic-controlled and uncontrolled groups, respectively. Indeed, the diabetic uncontrolled group showed a higher frequency of hypercholesterolemia, hypertriglyceridemia, hyper LDL-cholesterolemia, and hypo HDL-cholesterolemia compared to the diabetic controlled group. Lipid profiling analysis revealed significantly elevated (p<0.0001) levels of cholesterol, triglyceride, and low-density lipoprotein (LDL) in uncontrolled than the controlled group, while high-density lipoprotein (HDL) was significantly (p<0.0001) lower in uncontrolled diabetic patients. Interestingly, significantly (p<0.05) higher dyslipidemia was also observed in individuals with a controlled diabetic population, who have been suffering from T2DM for more than 7 years. Therefore, these results highlight that not only the diabetic uncontrolled but also the controlled group patients have a high risk of developing hyperlipidemia after a certain period of diabetes.

Keywords: Uncontrolled, Duration, Controlled, Hyperlipidemia, Diabetes

Results:

Classification of taxonomic ranks of viruses using VirusTaxo


Accuracy of VirusTaxo for order, family, and genus level classification in the pilot dataset.


Benchmarking of VirusTaxo for SARS-CoV-2 genomes

© Copyright 2023, Preonath Chondrow Dev